Progesterone treatment to prevent preterm birth

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Pharmacology

Background:

• Preterm delivery remains a significant challenge in obstetrics.
• Progesterone therapy has been investigated for preventing preterm birth.
• Recent large randomized trials have renewed interest in progestogen efficacy.

Purpose of the Study:

• To evaluate the efficacy of progesterone therapy in preventing preterm delivery.
• To synthesize findings from multiple randomized trials on progestogen use.
• To identify specific patient populations and treatment regimens showing benefit.

Main Methods:

• Systematic review and meta-analysis of randomized controlled trials.
• Inclusion of data from two large trials published in 2003 and previous smaller trials.
• Focus on singleton pregnancies at high risk for preterm labor.

Main Results:

• Progestogens, particularly 17alpha-hydroxyprogesterone caproate and progesterone vaginal suppositories, demonstrated efficacy in reducing recurrent preterm birth in high-risk singleton pregnancies.
• Six out of seven published trials reported significant protective effects.
• No successful trials were identified for multiple gestations.
• Progestogens were ineffective when administered after the onset of labor symptoms.

Conclusions:

• Progesterone therapy is a viable option for preventing recurrent preterm birth in specific high-risk singleton pregnancies.
• Treatment effectiveness is dependent on the progestogen used, administration route, and patient selection.
• Further research is needed for optimizing progestogen use in preventing preterm birth, especially in multiple gestations.